IL153288A0 - Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis - Google Patents

Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis

Info

Publication number
IL153288A0
IL153288A0 IL15328801A IL15328801A IL153288A0 IL 153288 A0 IL153288 A0 IL 153288A0 IL 15328801 A IL15328801 A IL 15328801A IL 15328801 A IL15328801 A IL 15328801A IL 153288 A0 IL153288 A0 IL 153288A0
Authority
IL
Israel
Prior art keywords
growth hormone
hematopoiesis
medicament
derivative
preparation
Prior art date
Application number
IL15328801A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL153288A0 publication Critical patent/IL153288A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL15328801A 2000-06-07 2001-06-01 Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis IL153288A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00111834 2000-06-07
PCT/EP2001/006249 WO2001093900A1 (en) 2000-06-07 2001-06-01 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (1)

Publication Number Publication Date
IL153288A0 true IL153288A0 (en) 2003-07-06

Family

ID=8168902

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15328801A IL153288A0 (en) 2000-06-07 2001-06-01 Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis

Country Status (10)

Country Link
US (1) US20040028649A1 (de)
EP (1) EP1286689B1 (de)
JP (1) JP2003535144A (de)
AT (1) ATE444078T1 (de)
AU (2) AU2001281800B2 (de)
CA (1) CA2409197A1 (de)
DE (1) DE60140051D1 (de)
ES (1) ES2330193T3 (de)
IL (1) IL153288A0 (de)
WO (1) WO2001093900A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
EP1016413A1 (de) * 1998-12-30 2000-07-05 Applied Research Systems ARS Holding N.V. Menschliches Wachstumshormon (HGH) zur Stimulierung der Mobilisierung pluripotenter Hämatopoietischer Stammzellen
US7288521B2 (en) * 2000-04-06 2007-10-30 Franco Wayne P Growth factor therapy mobilization of stem cells into the peripheral blood
US20040265971A1 (en) * 2001-11-19 2004-12-30 Hidetaka Sato Drug mobilizing pluripotent stem cells from tissue into peripheral blood
KR20050093759A (ko) 2002-09-18 2005-09-23 오르토-맥네일 파마슈티칼, 인코퍼레이티드 혈소판 및 조혈 줄기세포의 생산을 증가시키는 방법
US20040149235A1 (en) * 2002-10-04 2004-08-05 Pogue Albert S. Apparatus and method for removal of waste from animal production facilities
EP1656451A2 (de) 2003-08-13 2006-05-17 Children's Hospital Medical Center Chimäre peptide für regulierung von gtpasen
US7417026B2 (en) 2003-08-13 2008-08-26 Children's Hospital Medical Center Mobilization of hematopoietic cells
WO2005041865A2 (en) 2003-10-21 2005-05-12 Igf Oncology, Llc Compounds and method for treating cancer
US9011880B2 (en) 2003-10-21 2015-04-21 Igf Oncology, Llc Compounds and methods for treating cancer
WO2005072292A2 (en) * 2004-01-24 2005-08-11 Hugh Mctavish Methods for enhancing radiation therapy
US7615533B2 (en) * 2004-08-16 2009-11-10 Janssen Pharmaceutica N.V. TPO peptide compounds for treatment of anemia
EP1812082B1 (de) 2004-10-21 2013-08-14 IGF Oncology, LLC An IGF-1-Rezeptorliganden gekoppelte Toxine und Radionuklide zur Krebsbehandlung
KR20090112720A (ko) * 2007-02-13 2009-10-28 헬신 세라퓨틱스 (유.에스.) 인크. 성장 호르몬 분비촉진제를 이용한 세포 증식 질환의 치료방법
US20100226894A1 (en) * 2009-03-09 2010-09-09 Alex Wah Hin Yeung Mobilization of a complete cells mixture with embryonic like stem cells from the peripheral blood
US20130028870A1 (en) * 2011-01-31 2013-01-31 Royal Daniel F Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease
WO2012131733A2 (en) * 2011-03-31 2012-10-04 Godavari Biorefineries Limited Media compositions, method of initiating and enriching cultures of stem cells and/or cancer stem-like cells
US10092658B2 (en) 2012-02-07 2018-10-09 Phi Biomed Co., Ltd. Method for manufacturing transdermally delivered hyaluronic acid-protein conjugate and transdermally delivered hyaluronic acid-protein conjugate manufactured using same
EP3094339B1 (de) 2014-01-12 2019-12-11 IGF Oncology, LLC Fusionsproteine mit insulinähnlichem wachstumsfaktor-1 und epidermalem wachstumsfaktor sowie varianten davon
AU2018273370A1 (en) 2017-05-21 2019-10-31 Igf Oncology, Llc An insulin-like growth factor-chemotherapeputic conjugate for treating myelodysplastic syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19549232C2 (de) * 1995-12-20 1998-05-20 Boehringer Mannheim Gmbh Verwendung von G-CSF in Kombination mit einem Chemotherapeutikum bei der Behandlung von Erkrankungen, die eine periphere Stammzelltransplantation erfordern
PT1016414E (pt) * 1998-12-17 2004-12-31 Applied Research Systems Hormona de crescimento humano para estimular a hematopoiese e a reconstituicao imnologica apos transplante de celulas estaminais hematopoieticas em humanos
EP1016413A1 (de) * 1998-12-30 2000-07-05 Applied Research Systems ARS Holding N.V. Menschliches Wachstumshormon (HGH) zur Stimulierung der Mobilisierung pluripotenter Hämatopoietischer Stammzellen

Also Published As

Publication number Publication date
WO2001093900A1 (en) 2001-12-13
JP2003535144A (ja) 2003-11-25
EP1286689A1 (de) 2003-03-05
AU2001281800B2 (en) 2005-12-22
CA2409197A1 (en) 2001-12-13
DE60140051D1 (de) 2009-11-12
AU8180001A (en) 2001-12-17
ES2330193T3 (es) 2009-12-07
ATE444078T1 (de) 2009-10-15
EP1286689B1 (de) 2009-09-30
US20040028649A1 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
IL153288A0 (en) Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis
UA81390C2 (en) Use of unrestricted somatic stem cells (ussc) for the preparation of medicinal agents
HK1097449A1 (en) Methods for in vivo delivery of biologics and compositions useful therefor
GEP20053473B (en) High Potency Dihydroergotamine Compositions
IL173369A (en) Combined pharmaceutical preparation containing g - csf and p1gf effective in stimulating mobilization of peripheral blood progenitor cells
WO2005011769A3 (en) Implantable or insertable medical devices containing acrylic copolymer for controlled delivery of therapeutic agent
EP2548880A3 (de) Zusammensetzungen zur Erhöhung der Telomeraseaktivität
TW200501983A (en) Uses of anti-insulin-like growth factor I receptor antibodies
ATE387430T1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
SI1131065T1 (en) Dialkylfumarates for the treatment of autoimmune diseases
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
AU7315301A (en) Compounds and compositions for delivering active agents
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
ATE332136T1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
TW200635948A (en) Tripeptide and tetrapeptide thioethers
TR200401603T4 (tr) D vitamini benzerleri
HUP0301349A2 (hu) IL-11-tartalmú készítmények
BR0110049A (pt) Agonista de cxcr4, uso de um agonista de cxcr4, e composição farmacêutica
CO5650216A2 (es) Estuche para uso farmaceutico
BRPI0418157A (pt) terapêutica de tumores alogênicos
MXPA03010628A (es) Analogos de vitamina d.
IL158216A0 (en) Disposable vaginal cannula for the simultaneous administration of drugs in different forms
AU2503900A (en) Sulfated phosphatidylinositols, their preparation and use
GB0018322D0 (en) Pharmaceutical compositions